Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$0.5 - $0.73 $1,335 - $1,949
-2,670 Reduced 2.79%
92,985 $49,000
Q4 2023

Feb 07, 2024

SELL
$0.48 - $0.7 $5,101 - $7,439
-10,628 Reduced 10.0%
95,655 $54,000
Q3 2023

Nov 02, 2023

BUY
$0.5 - $1.05 $4,709 - $9,888
9,418 Added 9.72%
106,283 $63,000
Q2 2023

Aug 07, 2023

SELL
$0.55 - $0.89 $36,895 - $59,703
-67,083 Reduced 40.92%
96,865 $73,000
Q1 2023

May 09, 2023

SELL
$0.68 - $1.25 $12,724 - $23,390
-18,712 Reduced 10.24%
163,948 $116,000
Q4 2022

Feb 09, 2023

BUY
$0.96 - $1.34 $59,784 - $83,449
62,276 Added 51.73%
182,660 $188,000
Q3 2022

Nov 09, 2022

SELL
$1.02 - $2.23 $2,953 - $6,458
-2,896 Reduced 2.35%
120,384 $159,000
Q2 2022

Aug 10, 2022

SELL
$0.94 - $1.94 $5,906 - $12,189
-6,283 Reduced 4.85%
123,280 $127,000
Q1 2022

May 09, 2022

BUY
$1.54 - $3.71 $4,267 - $10,280
2,771 Added 2.19%
129,563 $255,000
Q4 2021

Feb 09, 2022

SELL
$2.58 - $3.91 $100,369 - $152,110
-38,903 Reduced 23.48%
126,792 $338,000
Q3 2021

Nov 09, 2021

BUY
$2.77 - $4.05 $33,356 - $48,770
12,042 Added 7.84%
165,695 $561,000
Q2 2021

Aug 10, 2021

BUY
$1.71 - $4.14 $262,746 - $636,123
153,653 New
153,653 $590,000
Q2 2020

Aug 05, 2020

SELL
$0.39 - $0.69 $11,566 - $20,464
-29,658 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$0.83 - $1.3 $2,871 - $4,498
3,460 Added 13.21%
29,658 $27,000
Q3 2019

Nov 13, 2019

SELL
$0.97 - $1.94 $14,906 - $29,813
-15,368 Reduced 36.97%
26,198 $26,000
Q2 2019

Aug 12, 2019

BUY
$1.81 - $2.45 $28,076 - $38,004
15,512 Added 59.54%
41,566 $85,000
Q1 2019

May 10, 2019

BUY
$2.3 - $3.27 $1,828 - $2,599
795 Added 3.15%
26,054 $64,000
Q4 2018

Feb 14, 2019

BUY
$2.49 - $4.54 $27,566 - $50,262
11,071 Added 78.03%
25,259 $65,000
Q3 2018

Nov 14, 2018

BUY
$3.4 - $4.84 $48,239 - $68,669
14,188 New
14,188 $68,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $242M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.